Neovii
Bahaa El Sayed is an experienced credit risk analyst currently working at Uniper since May 2022, focusing on LNG, coal, and freight, as well as global commodities. Prior to Uniper, Bahaa El Sayed held various positions at RBC from January 2009 to February 2022, including credit analyst roles in mortgage and car loans, national communication advisor, business banking advisor, and bilingual sales and service representative. Bahaa El Sayed holds a Bachelor of Science in Administration & Management Sciences from Université de Montréal and two certificates from HEC Montréal in Human Resources Management and Business Management.
This person is not in any teams
This person is not in any offices
Neovii
Neovii is a global leader in polyclonal antibody immunosuppressive therapy used in organ transplantation and hematology/oncology. Our lead product, Grafalon®, has been used for over 30 years to treat patients and is available in more than 40 countries world wide. It has approval for use in immunosuppressive therapies for prevention of graft- versus- host disease in stem cell transplantation, prevention and treatment of rejection in solid organ transplantation and in treatment of aplastic anemia.